Funding Status: IPO
Industry: Preclinical Development
Estimated Revenue: $50M to $100M
Technology: Biopharma, Biotechnology, Genetics, Health Care, Therapeutics
Headquarters: Emeryville, California, United States
Total Funding: 267567756.0
Last Funding Date: 2018-10-10
Last Funding Type: Series E
Employee Number: 101-250
Investors Number: 14.0
Founded Date: 2011-01-01